As recently reported, these changes may contribute to HIF-1α dependent protection of Ewing cells from anti-cancer drug- or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis [43], [63]. This evidence concerns the gene HIF1A and cancer.